New Approach Might Provide Potential Treatment for Flesh-Eating Bacteria

Scientists at the Houston Methodist Research Institute say they have found an important target on which to focus for developing a potential Group A Streptococcus (GAS) vaccine or antibiotic to fight it. GAS infections cause several million cases of strep throat every year, but also can lead to more severe infections, such as flesh-eating disease and acute rheumatic heart disease, according to the researchers. By manipulating this target, they hope to either reduce the severity of